Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
This innovative product eliminates two manufacturing steps and simplifies equipment setup
The company will submit its comprehensive response on these observations to the USFDA
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The inspection closed with the facility receiving an inspection classification of NAI
Urges Innovators to produce quality products that can be deployed at scale
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
